The FDAs existing Advanced Manufacturing Technologies Designation Program recognizes but does not fully resolve this inertia
10.1016/S1875-5364(14)60022-4 113 LiuP.WuS
Two industry data points add useful market context
Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis
The latter hypothesis derives from observations that GIP modulates vascular tone across peripheral vascular beds by enhancing endothelial nitric-oxide synthesis through eNOS activationan effect abolished by CaMKK, PLC, or AMPK inhibitionand demonstrates anti-inflammatory actions in adipose tissue and endothelium that correlate with increased cAMP signaling in select vascular beds, though a direct cAMP-dependent mechanism underlying its anti-inflammatory effect has yet to be conclusively established 49
Furthermore, nanomaterials can enhance drug retention, prevent biodegradation, and reduce drug removal, enabling lower doses [190, 191]